EXPO 80.95 Exponent Inc $EXPO Hit a 52 week high of 80.95

New Post Public Reply Private Reply Replies (0) Message Board

Nov 13, 2014 at 11:39 AM

EXPO 80.95 Exponent Inc $EXPO Hit a 52 week high of 80.95 Closing the day 09:40 at 80.95 +0.16 +0.20% With a day low of 79.65 and a total volume of 1,127.

EXPO Recent Posts: http://investorshangout.com/Exponent-EXPO-54069/

EXPO Exponent Inc Recent Headline News

ADT Beats on Q4 Earnings, Offers Initial 2015 Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 8:53AM CST
Adjusted net income for ADT stood at $97 million or 55 cents per share in the reported quarter, versus $99 million or 46 cents per share in the year-ago quarter.
CBZ: 8.98 (-0.06), EXPO: 79.57 (-1.22), IT: 85.95 (+0.33), ADT: 35.25 (-1.52)

FTI Consulting Tops Q3 Earnings & Guides Higher; Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 11:00AM CDT
FTI Consulting (FCN) continued its streak of beating earnings estimates, witnessing its fifth successive earnings beat. Adjusted earnings came in at 63 cents per share that surpassed the Zacks Consensus Estimate of 41 cents.
CBZ: 8.98 (-0.06), EXPO: 79.57 (-1.22), CLGX: 31.07 (-0.05), FCN: 41.24 (+0.23)

Republic Services (RSG) Misses on Q3 Earnings by a Whisker - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 9:40AM CDT
Republic Services, Inc (RSG) reported GAAP net income of $185.8 million or 52 cents per share in third-quarter 2014 versus $171.4 million or 47 cents per share in the year-ago quarter.
EXPO: 79.57 (-1.22), WCN: 50.44 (-0.02), RSG: 39.63 (-0.01), III: 4.38 (-0.04)

Vistaprint Beats Q1 Earnings on Operational Excellence - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 10:00AM CDT
Vistaprint N.V. (VPRT) reported solid first-quarter fiscal 2015 results as revenues and adjusted earnings improved year over year due to the successful implementation of major pricing and marketing changes.
PAYX: 47.56 (+0.07), EXPO: 79.57 (-1.22), VPRT: 67.26 (-1.12), III: 4.38 (-0.04)

Waste Management (WM) Outshines Q3 Earnings Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 2:20PM CDT
Waste Management (WM) reported net income of $270 million or 58 cents per share in the third quarter of 2014 versus $291 million or 62 cents per share in the year-ago period.
EXPO: 79.57 (-1.22), WCN: 50.44 (-0.02), III: 4.38 (-0.04), WM: 49.39 (+0.01)

Navigant (NCI) Q3 Earnings, Revenues Top Estimates, Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 1:50PM CDT
Navigant (NCI) reported strong results as its adjusted earnings for the third quarter came in at 32 cents per share, up 28% from 25 cents in the year-ago quarter and comfortably ahead of the Zacks Consensus Estimate of 27 cents.
CBZ: 8.98 (-0.06), EXPO: 79.57 (-1.22), CLGX: 31.07 (-0.05), NCI: 15.29 (-0.14)

Exponent's (EXPO) CEO Paul Johnston on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Oct 22, 8:08PM CDT

EXPO: 79.57 (-1.22)

Exponent tops Street 3Q forecasts
Automated Insights - Wed Oct 22, 6:39PM CDT
MENLO PARK, Calif. (AP) _ Exponent Inc. (EXPO) on Wednesday reported third-quarter earnings of $11 million.
EXPO: 79.57 (-1.22)

Exponent declares $0.25 dividend
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 4:42PM CDT

EXPO: 79.57 (-1.22)

Exponent beats by $0.09, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 3:45PM CDT

EXPO: 79.57 (-1.22)

Exponent (EXPO) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Oct 22, 3:25PM CDT

EXPO: 79.57 (-1.22)

Exponent Reports Solid Third Quarter Fiscal 2014 Results
GlobeNewswire - Wed Oct 22, 3:14PM CDT
Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the third quarter and nine months ended October 3, 2014.
EXPO: 79.57 (-1.22)

Exponent Declares Regular Quarterly Dividend
GlobeNewswire - Wed Oct 22, 3:12PM CDT
Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.25 per share of common stock to be paid on Dec 19, 2014 to all common stockholders of record as of November 28, 2014.
EXPO: 79.57 (-1.22)

Exponent to Announce Third Quarter of Fiscal 2014 Results
GlobeNewswire - Thu Oct 09, 3:05PM CDT
Exponent, Inc. (Nasdaq:EXPO), today announced that it will release financial results for the third quarter ended October 3, 2014, immediately following the close of the market on Wednesday, October 22, 2014. The Company will conduct a conference call to discuss its third quarter financial results as follows:
EXPO: 79.57 (-1.22)

How To YieldBoost EXPO To 6.9% Using Options
StockOptionsChannel.com - Wed Aug 13, 10:32AM CDT
Shareholders of Exponent Inc. looking to boost their income beyond the stock's 1.4% annualized dividend yield can sell the March 2015 covered call at the $80 strike and collect the premium based on the $2.40 bid, which annualizes to an additional...
EXPO: 79.57 (-1.22)

Exponent to Present at Jefferies 2014 Global Industrials Conference
GlobeNewswire - Wed Aug 06, 3:50PM CDT
Exponent, Inc. (Nasdaq:EXPO) today announced that Richard Schlenker, Executive Vice President and Chief Financial Officer will present to the investment community at the Jefferies 2014 Global Industrials Conference on Thursday, August 14, 2014 at 2:30 pm ET. The conference is being held at the Grand Hyatt in New York City.
EXPO: 79.57 (-1.22)

Will Office Depot (ODP) Keep the Earnings Streak Alive? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 04, 11:31AM CDT
Office Depot (ODP), the supplier of a range of office products and services, is slated to report its second-quarter 2014 results on Aug 5.
EXPO: 79.57 (-1.22), ADM: 50.44 (-0.27), ODP: 6.78 (-0.06), TWX: 79.17 (+1.49)

Will Meredith (MDP) Keep the Earnings Streak Alive in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 4:15PM CDT
Meredith Corporation (MDP) is slated to report its fourth-quarter fiscal 2014 results on Jul 31.
MDP: 51.31 (+0.09), EXPO: 79.57 (-1.22), BIG: 48.62 (+0.23), TWX: 79.17 (+1.49)

Will Thomson Reuters (TRI) Earnings Miss Estimates in Q2? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 29, 3:56PM CDT
Thomson Reuters (TRI), provider of information related to financial & risk, legal, tax & accounting, and intellectual property & science, is slated to report second-quarter 2014 results on Jul 30.
EXPO: 79.57 (-1.22), TRI: 38.16 (-0.08), NCI: 15.29 (-0.14), TWX: 79.17 (+1.49)

Exponent Reports Second Quarter Fiscal 2014 Results
GlobeNewswire - Tue Jul 22, 3:11PM CDT
Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the second quarter and six months ended July 4, 2014.
EXPO: 79.57 (-1.22)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Master Sommeliers and Italian Producers Clash on Wine Lists

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Aluminum Design Fumble: Geometry Over Wall Thickness

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Swanson Nexus Pro Launch: Boost for Dietitians

By Lucas Young Updated Oct 24, 2026 Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Love Business Group Helps SMEs Navigate Broadband Choices

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...